IR
46
3
AMT
30
2
PBI
30
-8
MAR
57
3
ED
39
8
EA
41
3
PWR
63
3
ROP
44
6
HAS
29
3
F
38
4
PEP
33
4
O
26
16
GD
42
4
FIS
43
5
PH
60
5
CMA
42
3
AIV
39
6
WMB
58
3
CLX
65
2
AFL
34
6
IR
46
3
AMT
30
2
PBI
30
-8
MAR
57
3
ED
39
8
EA
41
3
PWR
63
3
ROP
44
6
HAS
29
3
F
38
4
PEP
33
4
O
26
16
GD
42
4
FIS
43
5
PH
60
5
CMA
42
3
AIV
39
6
WMB
58
3
CLX
65
2
AFL
34
6
Financhill
Back

Aytu BioPharma Quote, Financials, Valuation and Earnings

The Trump Nuclear MEGA-Boom!

Here's why nuclear stocks are expected to skyrocket under Trump's second term.
Sell
19

AYTU
Aytu BioPharma

Last Price:
$1.36
Seasonality Move:
154.39%

7 Day Trial

ALL ACCESS PASS

$ 7

These 7 Stocks Will Be Magnificent in 2025

Get Your Copy of "These 7 Stocks Will Be Magnificent in 2025" Here.

Aytu BioPharma Price Quote

$1.36
-0.03 (-1.45%)
(Updated: December 22, 2024 at 4:00 AM ET)

Aytu BioPharma Key Stats

Sell
19
Aytu BioPharma (AYTU) is a Sell
Day range:
$1.35 - $1.44
52-week range:
$1.30 - $3.45
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
0.12
P/B ratio:
0.29%
Volume:
25.2K
Avg. volume:
46.2K
1-year change:
-51.4%
Market cap:
$8.5M
Revenue:
$81M
EPS:
$-1.53

How Much Does Aytu BioPharma Make?

Data Unavailable

Is Aytu BioPharma Growing As A Company?

Data Unavailable

Aytu BioPharma Stock Price Performance

  • Did Aytu BioPharma Stock Go Up Last Month?
    Aytu BioPharma share price went down by -6.71% last month
  • Did AYTU's Share Price Rise Over The Last Year?
    AYTU share price fell by -51.4% over the past 1 year

What Is Aytu BioPharma 52-Week High & Low?

Aytu BioPharma Price To Free Cash Flow

Data Unavailable

Is It Risky To Buy Aytu BioPharma?

Data Unavailable

Is Aytu BioPharma Cash Flow Positive?

Data Unavailable

Aytu BioPharma Return On Invested Capital

Data Unavailable

Aytu BioPharma Earnings Date & Stock Price

Aytu BioPharma Competitors

  • Who Are Aytu BioPharma's Competitors?
    Below is a list of companies who compete with Aytu BioPharma or are related in some way:
    • Achieve Life Sciences Inc (ACHV)
    • Bristol-Myers Squibb Co (BMY)
    • CEL-SCI Corp (CVM)
    • enVVeno Medical Corp (NVNO)
    • Telesis Bio Inc (TBIO)

Aytu BioPharma Dividend Yield

Data Unavailable

Aytu BioPharma Analyst Estimates

YoY Growth Past Surprise
EPS: 0% 0%
Revenue: -6.98% 20.38%

Analyst Recommendations

Buy Recommendations: 0
Hold Recommendations: 0
Sell Recommendations: 0
Price Target: 0.00
Downside from Last Price: -100%

Major Shareholders

Data Unavailable